NGL Fine-Chem has signed Agreement to acquire, subject to terms and conditions stated in the Agreement, 100% equity shares of Macrotech Polychem for a cash consideration of Rs 7 crore.
No regulatory approvals are required for this investment. The investment does not fall within related party transactions and none of company's promoter/promoter group have any interest in the transaction.
NGL Fine-Chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.
